These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 29125546

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
    Neocleous V, Skordis N, Shammas C, Efstathiou E, Mastroyiannopoulos NP, Phylactou LA.
    Metabolism; 2012 Jul; 61(7):922-30. PubMed ID: 22386940
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The vasopressin-aquaporin-2 pathway syndromes.
    Valenti G, Tamma G.
    Handb Clin Neurol; 2021 Jul; 181():249-259. PubMed ID: 34238461
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Hereditary nephrogenic diabetes insipidus].
    Morin D, Ala Y, Dumas R.
    Arch Pediatr; 1995 Jun; 2(6):560-7. PubMed ID: 7640759
    [Abstract] [Full Text] [Related]

  • 51. Genetic analysis of nephrogenic diabetes insipidus patients: A study on the Iranian population.
    Ghasemi S, Mojbafan M, Talebi S, Hooman N, Hoseini R.
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2421. PubMed ID: 38622833
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Expression of a dominant negative PKA mutation in the kidney elicits a diabetes insipidus phenotype.
    Gilbert ML, Yang L, Su T, McKnight GS.
    Am J Physiol Renal Physiol; 2015 Mar 15; 308(6):F627-38. PubMed ID: 25587115
    [Abstract] [Full Text] [Related]

  • 55. Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus.
    Bouley R, Hasler U, Lu HA, Nunes P, Brown D.
    Semin Nephrol; 2008 May 15; 28(3):266-78. PubMed ID: 18519087
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families.
    Sahakitrungruang T, Tee MK, Rattanachartnarong N, Shotelersuk V, Suphapeetiporn K, Miller WL.
    Horm Res Paediatr; 2010 May 15; 73(5):349-54. PubMed ID: 20389105
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.